Pancreatic Cancer Research

ResearcherTohoku UniversityActive in the last 2 years

Mitsuhiro Shimura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4147-8081; OpenAlex author ID A5041303957. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 2 papers

Papers 7

  1. Histological treatment response to neoadjuvant chemotherapy predicts the survival outcomes of patients with resectable pancreatic cancer: validation of the Jap… Co-author DOI 10.1007/s00595-026-03325-w↗
  2. SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancreatic cancer. Co-author DOI 10.1016/j.pan.2026.03.007↗
  3. Preoperative Chemotherapy With Gemcitabine for Pancreatic Cancer Causes Zinc Deficiency. Co-author DOI 10.1097/mpa.0000000000002396↗
  4. Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Preceding Neoadjuvant Therapy for Pancreatic Duc… Co-author DOI 10.1097/mpa.0000000000002503↗
  5. Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. Co-author DOI 10.1016/j.pan.2022.11.010↗
  6. Stromal expression of hemopexin is associated with lymph-node metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0235904↗
  7. A long-term survival case treated with conversion surgery following chemotherapy after diagnostic metastasectomy for pancreatic cancer with synchronous liver m… Co-author DOI 10.1186/s40792-017-0409-9↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masahiro Iseki · 7 shared papers, 2017–2026 · strength 1.19
  2. Masamichi Mizuma · 7 shared papers, 2017–2026 · strength 1.19
  3. Michiaki Unno · 7 shared papers, 2017–2026 · strength 1.19
  4. Shuichi Aoki · 5 shared papers, 2023–2026 · strength 1.04
  5. Daisuke Douchi · 5 shared papers, 2023–2026 · strength 1.04
  6. Shimpei Maeda · 5 shared papers, 2017–2026 · strength 0.95
  7. Kei Nakagawa · 4 shared papers, 2017–2025 · strength 0.50
  8. Fuyuhiko Motoi · 4 shared papers, 2017–2025 · strength 0.49
  9. Atsushi Masamune · 2 shared papers, 2026 · strength 0.49
  10. Koetsu Inoue · 2 shared papers, 2025–2026 · strength 0.45
  11. Shingo Yoshimachi · 2 shared papers, 2025–2026 · strength 0.44
  12. Koetsu Inoue · 2 shared papers, 2023–2025 · strength 0.35
  13. Takanori Morikawa · 3 shared papers, 2017–2023 · strength 0.29
  14. Yuichiro Umino · 1 shared paper, 2026 · strength 0.24
  15. Naohiro Hirano · 1 shared paper, 2026 · strength 0.24
  16. Toru Furukawa · 1 shared paper, 2026 · strength 0.24
  17. Takashi Kokumai · 1 shared paper, 2025 · strength 0.21
  18. Aya Noguchi · 1 shared paper, 2025 · strength 0.20
  19. Tatsuo Hata · 2 shared papers, 2017–2020 · strength 0.14
  20. Tatsuyuki Takadate · 2 shared papers, 2017–2020 · strength 0.14
  21. Kei Kawaguchi · 1 shared paper, 2020 · strength 0.09
  22. Yukie Suzuki · 1 shared paper, 2020 · strength 0.09
  23. Takashi Suzuki · 1 shared paper, 2020 · strength 0.09
  24. Kazuhiko Igarashi · 1 shared paper, 2020 · strength 0.09
  25. Kyohei Ariake · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.